Global Markets Direct is a cutting-edge provider of market research and business consultancies for a wide range of customers worldwide.
A team of analytics is capable to produce all sorts of market information and carry out extensive industry research using unique data and reliable sources to let customers know who they are at the market. Global Markets Direct has profound analytical experience in researching the industries and preparing customized reports across many specific fields.
The company is distinguished by its high-quality consulting products and close inspection of the issues under study. Diligent efforts of the experts make every piece of business information an exclusive source of feasible solutions and valuable advice.
With a commitment to serve every client need, Global Markets Direct collects and interprets the materials for the analysis, uses methods of primary and secondary research and develops one of a kind data packages for global clients. They are able to cover the tones of industry-related information to assist customers in taking the right business decisions and developing their strategic plans.
Under the supervision of skillful managers and experts, business analysts produce reports that include:
- Product portfolio
- Potentially strong market reviews
- Competitive analytics
- Prospect partners
- Mergers and acquisitions project data
- Latest trends across a particular industry area
- Research and development strategies
- The analysis of new customers
- A set of remedial measures for projects
They will search for new partners and highlight the current business issues plus develop new strategies and tactical steps to help you take the lead in the industry where you operate.
Publications found:
2,110
Sort by:
Benign Prostatic Hyperplasia - Pipeline Review, H1 2020
US$ 2,000.00
... . The Benign Prostatic Hyperplasia (Male Health) pipeline guide also reviews of key players involved in therapeutic development for Benign Prostatic Hyperplasia and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
May 2020
121 pages
Gastritis - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Gastritis (Gastrointestinal) pipeline guide also reviews of key players involved in therapeutic development for Gastritis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
May 2020
80 pages
Chondrosarcoma - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Chondrosarcoma (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Chondrosarcoma and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
May 2020
481 pages
Amyotrophic Lateral Sclerosis - Pipeline Review, H1 2020
US$ 2,500.00
... . The Amyotrophic Lateral Sclerosis (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Amyotrophic Lateral Sclerosis and features dormant and discontinued projects. The guide covers therapeutics under Development ...
May 2020
759 pages
Anaplastic Astrocytoma - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Anaplastic Astrocytoma (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Anaplastic Astrocytoma and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
May 2020
235 pages
Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Ankylosing Spondylitis (Bekhterev's Disease) (Musculoskeletal Disorders) pipeline guide also reviews of key players involved in therapeutic development for Ankylosing Spondylitis (Bekhterev's Disease) and features dormant and discontinued projects. The guide covers therapeutics under Development ...
May 2020
226 pages
Aspergillosis - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Aspergillosis (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Aspergillosis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
May 2020
188 pages
Cervical Cancer - Pipeline Review, H1 2020
US$ 2,500.00
... releases. The Cervical Cancer (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Cervical Cancer and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
May 2020
1460 pages
Cytomegalovirus (HHV-5) Infections - Pipeline Review, H1 2020
US$ 2,000.00
... . The Cytomegalovirus (HHV-5) Infections (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Cytomegalovirus (HHV-5) Infections and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
May 2020
191 pages
Endometrial Cancer - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Endometrial Cancer (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Endometrial Cancer and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
May 2020
1456 pages
Ewing Sarcoma - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Ewing Sarcoma (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Ewing Sarcoma and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
May 2020
701 pages
Gouty Arthritis (Gout) - Pipeline Review, H1 2020
US$ 2,000.00
... . The Gouty Arthritis (Gout) (Musculoskeletal Disorders) pipeline guide also reviews of key players involved in therapeutic development for Gouty Arthritis (Gout) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
May 2020
125 pages
Insomnia - Pipeline Review, H1 2020
US$ 2,000.00
... . The Insomnia (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Insomnia and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
May 2020
158 pages
Irritable Bowel Syndrome - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Irritable Bowel Syndrome (Gastrointestinal) pipeline guide also reviews of key players involved in therapeutic development for Irritable Bowel Syndrome and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
May 2020
160 pages
Melanoma - Pipeline Review, H1 2020
US$ 2,500.00
... releases. The Melanoma (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Melanoma and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
May 2020
999 pages
Migraine - Pipeline Review, H1 2020
US$ 2,000.00
... . The Migraine (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Migraine and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
May 2020
313 pages
Neuroblastoma - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Neuroblastoma (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Neuroblastoma and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
May 2020
915 pages
Obesity - Pipeline Review, H1 2020
US$ 2,500.00
... releases. The Obesity (Metabolic Disorders) pipeline guide also reviews of key players involved in therapeutic development for Obesity and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
May 2020
592 pages
Respiratory Syncytial Virus (RSV) Infections - Pipeline Review, H1 2020
US$ 2,000.00
... . The Respiratory Syncytial Virus (RSV) Infections (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Respiratory Syncytial Virus (RSV) Infections and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
May 2020
292 pages
Spinal Cord Injury - Pipeline Review, H1 2020
US$ 2,000.00
... . The Spinal Cord Injury (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Spinal Cord Injury and features dormant and discontinued projects. The guide covers therapeutics under Development ...
May 2020
243 pages
Systemic Lupus Erythematosus - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Systemic Lupus Erythematosus (Immunology) pipeline guide also reviews of key players involved in therapeutic development for Systemic Lupus Erythematosus and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
May 2020
717 pages
Tuberculosis - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Tuberculosis (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Tuberculosis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
May 2020
405 pages
Vancomycin-Resistant Enterococcus faecium Infections - Pipeline Review, H1 2020
US$ 2,000.00
... The Vancomycin-Resistant Enterococcus faecium Infections (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Vancomycin-Resistant Enterococcus faecium Infections and features dormant and discontinued projects. The guide covers therapeutics under Development ...
May 2020
96 pages
Cancer Pain - Pipeline Review, H1 2020
US$ 2,000.00
... . The Cancer Pain (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Cancer Pain and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
May 2020
155 pages
Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H1 2020
US$ 2,500.00
... releases. The Chronic Lymphocytic Leukemia (CLL) (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Chronic Lymphocytic Leukemia (CLL) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
May 2020
1353 pages
Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Chronic Myelocytic Leukemia (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
May 2020
598 pages
Diabetic Foot Ulcers - Pipeline Review, H1 2020
US$ 2,000.00
... . The Diabetic Foot Ulcers (Metabolic Disorders) pipeline guide also reviews of key players involved in therapeutic development for Diabetic Foot Ulcers and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
May 2020
182 pages
Diabetic Neuropathy - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Diabetic Neuropathy (Metabolic Disorders) pipeline guide also reviews of key players involved in therapeutic development for Diabetic Neuropathy and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
May 2020
135 pages
Diabetic Retinopathy - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Diabetic Retinopathy (Metabolic Disorders) pipeline guide also reviews of key players involved in therapeutic development for Diabetic Retinopathy and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
May 2020
324 pages
Hypercholesterolemia - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Hypercholesterolemia (Metabolic Disorders) pipeline guide also reviews of key players involved in therapeutic development for Hypercholesterolemia and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
May 2020
252 pages
Malaria - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Malaria (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Malaria and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
May 2020
394 pages
Prostate Cancer - Pipeline Review, H1 2020
US$ 2,500.00
... releases. The Prostate Cancer (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Prostate Cancer and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
May 2020
2967 pages
Psoriatic Arthritis - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Psoriatic Arthritis (Musculoskeletal Disorders) pipeline guide also reviews of key players involved in therapeutic development for Psoriatic Arthritis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
May 2020
282 pages
Type 1 Diabetes (Juvenile Diabetes) - Pipeline Review, H1 2020
US$ 2,500.00
... . The Type 1 Diabetes (Juvenile Diabetes) (Metabolic Disorders) pipeline guide also reviews of key players involved in therapeutic development for Type1 diabetes (Juvenile Diabetes) and features dormant and discontinued projects. The guide covers therapeutics under Development ...
May 2020
672 pages
Type 2 Diabetes - Pipeline Review, H1 2020
US$ 2,500.00
... . The Type 2 Diabetes (Metabolic Disorders) pipeline guide also reviews of key players involved in therapeutic development for Type2 diabetes and features dormant and discontinued projects. The guide covers therapeutics under Development ...
May 2020
1220 pages
Leishmaniasis (Kala-Azar) - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Leishmaniasis (Kala-Azar) (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Leishmaniasis (Kala-Azar) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
May 2020
140 pages
Non-Hodgkin Lymphoma - Pipeline Review, H1 2020
US$ 2,500.00
... Markets Direct's Pharmaceutical and Healthcare latest pipeline guide Non-Hodgkin Lymphoma - Pipeline Review, H1 2018, provides comprehensive information on the therapeutics under development for Non-Hodgkin Lymphoma (Oncology) The guide covers the ...
May 2020
3473 pages
Schizophrenia - Pipeline Review, H1 2020
US$ 2,000.00
... . The Schizophrenia (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Schizophrenia and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
May 2020
383 pages
Escherichia coli Infections - Pipeline Review, H1 2020
US$ 2,000.00
... . The Escherichia coli Infections (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Escherichia coli Infections and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
May 2020
200 pages
Diphtheria - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Diphtheria (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Diphtheria and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
May 2020
85 pages
Hepatitis B - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Hepatitis B (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Hepatitis B and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
May 2020
503 pages
Muscular Dystrophy - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Muscular Dystrophy (Musculoskeletal Disorders) pipeline guide also reviews of key players involved in therapeutic development for Muscular Dystrophy and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
May 2020
250 pages
Aplastic Anemia - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Aplastic Anemia (Hematological Disorders) pipeline guide also reviews of key players involved in therapeutic development for Aplastic Anemia and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
May 2020
110 pages
Herpes Labialis (Oral Herpes) - Pipeline Review, H1 2020
US$ 2,000.00
... . The Herpes Labialis (Oral Herpes) (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Herpes Labialis (Oral Herpes) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
May 2020
61 pages
Tularaemia - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Tularaemia (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Tularaemia and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
May 2020
40 pages
Cryptosporidiosis - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Cryptosporidiosis (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Cryptosporidiosis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
May 2020
30 pages
